294 related articles for article (PubMed ID: 30224477)
1. Control of CCND1 ubiquitylation by the catalytic SAGA subunit USP22 is essential for cell cycle progression through G1 in cancer cells.
Gennaro VJ; Stanek TJ; Peck AR; Sun Y; Wang F; Qie S; Knudsen KE; Rui H; Butt T; Diehl JA; McMahon SB
Proc Natl Acad Sci U S A; 2018 Oct; 115(40):E9298-E9307. PubMed ID: 30224477
[TBL] [Abstract][Full Text] [Related]
2. Deubiquitinating enzyme USP22 positively regulates c-Myc stability and tumorigenic activity in mammalian and breast cancer cells.
Kim D; Hong A; Park HI; Shin WH; Yoo L; Jeon SJ; Chung KC
J Cell Physiol; 2017 Dec; 232(12):3664-3676. PubMed ID: 28160502
[TBL] [Abstract][Full Text] [Related]
3. Knock-down of ubiquitin-specific protease 22 by micro-RNA interference inhibits colorectal cancer growth.
Xu H; Liu YL; Yang YM; Dong XS
Int J Colorectal Dis; 2012 Jan; 27(1):21-30. PubMed ID: 21773699
[TBL] [Abstract][Full Text] [Related]
4. Aggregation of Polyglutamine-expanded Ataxin 7 Protein Specifically Sequesters Ubiquitin-specific Protease 22 and Deteriorates Its Deubiquitinating Function in the Spt-Ada-Gcn5-Acetyltransferase (SAGA) Complex.
Yang H; Liu S; He WT; Zhao J; Jiang LL; Hu HY
J Biol Chem; 2015 Sep; 290(36):21996-2004. PubMed ID: 26195632
[TBL] [Abstract][Full Text] [Related]
5. USP22 acts as an oncogene by the activation of BMI-1-mediated INK4a/ARF pathway and Akt pathway.
Liu YL; Jiang SX; Yang YM; Xu H; Liu JL; Wang XS
Cell Biochem Biophys; 2012 Jan; 62(1):229-35. PubMed ID: 21928107
[TBL] [Abstract][Full Text] [Related]
6. USP22 regulates cell proliferation by deubiquitinating the transcriptional regulator FBP1.
Atanassov BS; Dent SY
EMBO Rep; 2011 Sep; 12(9):924-30. PubMed ID: 21779003
[TBL] [Abstract][Full Text] [Related]
7. USP22 drives colorectal cancer invasion and metastasis via epithelial-mesenchymal transition by activating AP4.
Li Y; Yang Y; Li J; Liu H; Chen F; Li B; Cui B; Liu Y
Oncotarget; 2017 May; 8(20):32683-32695. PubMed ID: 28427243
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-specific protease 22 (USP22) positively regulates RCAN1 protein levels through RCAN1 de-ubiquitination.
Hong A; Lee JE; Chung KC
J Cell Physiol; 2015 Jul; 230(7):1651-60. PubMed ID: 25546086
[TBL] [Abstract][Full Text] [Related]
9. The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression.
Zhang XY; Varthi M; Sykes SM; Phillips C; Warzecha C; Zhu W; Wyce A; Thorne AW; Berger SL; McMahon SB
Mol Cell; 2008 Jan; 29(1):102-11. PubMed ID: 18206973
[TBL] [Abstract][Full Text] [Related]
10. Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression.
Sun T; Zhang K; Li W; Liu Y; Pangeni RP; Li A; Arvanitis L; Raz DJ
Cell Commun Signal; 2022 Sep; 20(1):147. PubMed ID: 36123698
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of ubiquitin-specific protease 22 can promote cancer progression and predict therapy failure in human colorectal cancer.
Liu YL; Yang YM; Xu H; Dong XS
J Gastroenterol Hepatol; 2010 Nov; 25(11):1800-5. PubMed ID: 21039844
[TBL] [Abstract][Full Text] [Related]
12. USP22 acts as an oncogene by regulating the stability of cyclooxygenase-2 in non-small cell lung cancer.
Xiao H; Tian Y; Yang Y; Hu F; Xie X; Mei J; Ding F
Biochem Biophys Res Commun; 2015 May; 460(3):703-8. PubMed ID: 25817787
[TBL] [Abstract][Full Text] [Related]
13. USP22, an hSAGA subunit and potential cancer stem cell marker, reverses the polycomb-catalyzed ubiquitylation of histone H2A.
Zhang XY; Pfeiffer HK; Thorne AW; McMahon SB
Cell Cycle; 2008 Jun; 7(11):1522-4. PubMed ID: 18469533
[TBL] [Abstract][Full Text] [Related]
14. USP22 promotes resistance to EGFR-TKIs by preventing ubiquitination-mediated EGFR degradation in EGFR-mutant lung adenocarcinoma.
Zhang H; Han B; Lu H; Zhao Y; Chen X; Meng Q; Cao M; Cai L; Hu J
Cancer Lett; 2018 Oct; 433():186-198. PubMed ID: 29981430
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin-Specific Peptidase 22 Contributes to Colorectal Cancer Stemness and Chemoresistance via Wnt/β-Catenin Pathway.
Jiang S; Song C; Gu X; Wang M; Miao D; Lv J; Liu Y
Cell Physiol Biochem; 2018; 46(4):1412-1422. PubMed ID: 29689565
[TBL] [Abstract][Full Text] [Related]
16. USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma.
Ning Z; Wang A; Liang J; Xie Y; Liu J; Feng L; Yan Q; Wang Z
Int J Oncol; 2014 Oct; 45(4):1594-608. PubMed ID: 24993031
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin-specific peptidase USP22 negatively regulates the STAT signaling pathway by deubiquitinating SIRT1.
Ao N; Liu Y; Feng H; Bian X; Li Z; Gu B; Zhao X; Liu Y
Cell Physiol Biochem; 2014; 33(6):1863-75. PubMed ID: 24969755
[TBL] [Abstract][Full Text] [Related]
18. Immune Evasion and Drug Resistance Mediated by USP22 in Cancer: Novel Targets and Mechanisms.
Guo J; Zhao J; Fu W; Xu Q; Huang D
Front Immunol; 2022; 13():918314. PubMed ID: 35935969
[TBL] [Abstract][Full Text] [Related]
19. Gcn5 and SAGA regulate shelterin protein turnover and telomere maintenance.
Atanassov BS; Evrard YA; Multani AS; Zhang Z; Tora L; Devys D; Chang S; Dent SY
Mol Cell; 2009 Aug; 35(3):352-64. PubMed ID: 19683498
[TBL] [Abstract][Full Text] [Related]
20. USP22 promotes NSCLC tumorigenesis via MDMX up-regulation and subsequent p53 inhibition.
Ding F; Bao C; Tian Y; Xiao H; Wang M; Xie X; Hu F; Mei J
Int J Mol Sci; 2014 Dec; 16(1):307-20. PubMed ID: 25547493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
